Because of a previously unexploited weakness in tumor architecture, nanomaterials may offer a way to treat cancer without doing too much damage to healthy tissue. The weakness isn’t really a property of the tumors themselves but of the blood vessels that feed them.
No takes yet. Share an insight, caveat, or question.
Grossman et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: